SPHK1 and neoplasm: No differences were observed in tumor latency or tumor growth over time between MMTV-PyMT SK1-/- and MMTV-PyMT SK1+/+ mice (Fig 1A), suggesting that SK1 is not participating in the in vivo breast tumor progression in MMTV-PyMT mice.